QA: Arena Pharmaceuticals INC in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001080709_2017_Arena_Pharmaceuticals_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}
warning Large missing amount for aggregate "Revenues" added to remainder. industry.us_generic {'missing_ratio': 3.0676881685149944, 'aggregate_val': 123975000, 'exp_sum': 30478000, 'exp_to_value': {'remainder_Revenues': 30478000}}

Graph

Absolute values for 0001080709, Arena Pharmaceuticals INC

  xvar xval
0 AssetsCurrent 119,889,000
1 IntangibleAssetsNetIncludingGoodwill 2,357,000
2 PropertyPlantAndEquipmentNet 43,828,000
3 remainder_Assets 2,936,000
4 LiabilitiesCurrent 63,879,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 30,672,505
9 ResearchAndDevelopmentExpense 66,645,653
10 remainder_Expenses 65,381,354
11 remainder_Revenues 106,492,848
12 remainder_NetIncome -5,647,867
13 remainder_ComprehensiveNetIncome -1,074,032
  yvar yval
0 Assets 169,010,000
1 Liabilities 63,879,000
2 Expenses 162,699,512
3 Revenues 106,492,848
4 StockholdersEquity 105,131,000
5 NetIncome -61,854,531
6 ComprehensiveNetIncome -62,391,547
7 BaseVar 254,401,630
8 EconomicCapitalRatiobeforeLimitedLiability 1.43
9 EconomicCapitalRatio 2.63

Edgar->Model Mapping

Feature Distribution

Change over Time